VYNE Therapeutics Inc.

VYNE · Nasdaq · SIC 2834: Pharmaceutical Preparations
178
SEC Filings

Business Summary

PART I ITEM 1 - BUSINESS Overview We are a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat inflammatory and immune-mediated conditions with high unmet need. We have exclusive worldwide rights to research, develop and commercialize products containing small molecule bromodomain and extra-terminal domain (BET) inhibitors for the treatment of any disease, disorder or condition in humans, which we licensed from Tay Therapeutics Ltd., formerly known as...

Next Earnings

Q2 FY2026 — expected 2026-09-15

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionVYNEdiscussed_in_filing Cybersecurity
topic_mentionVYNEdiscussed_in_filing Trusted Computing
topic_mentionVYNEdiscussed_in_filing Blockchain & Crypto
topic_mentionVYNEdiscussed_in_filing Regulation
topic_mentionVYNEdiscussed_in_filing Automotive
topic_mentionVYNEdiscussed_in_filing Healthcare & Bio
topic_mentionVYNEdiscussed_in_filing Platform & Ecosystem
topic_mentionVYNEdiscussed_in_filing Sovereign & Government
topic_mentionVYNEdiscussed_in_filing Cybersecurity
topic_mentionVYNEdiscussed_in_filing Trusted Computing
topic_mentionVYNEdiscussed_in_filing Blockchain & Crypto
topic_mentionVYNEdiscussed_in_filing Regulation
topic_mentionVYNEdiscussed_in_filing Automotive
topic_mentionVYNEdiscussed_in_filing Healthcare & Bio
topic_mentionVYNEdiscussed_in_filing Platform & Ecosystem
topic_mentionVYNEdiscussed_in_filing Sovereign & Government
topic_mentionVYNEdiscussed_in_filing Cybersecurity
topic_mentionVYNEdiscussed_in_filing Trusted Computing
topic_mentionVYNEdiscussed_in_filing Blockchain & Crypto
topic_mentionVYNEdiscussed_in_filing Regulation

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-272025-12-310001566044-26-000002EDGAR89K words
2025-03-062024-12-310001628280-25-010908EDGAR—
2024-03-012023-12-310001628280-24-008178EDGAR—
2023-03-142022-12-310001628280-23-007900EDGAR—
2022-03-172021-12-310001628280-22-006545EDGAR—
2021-03-042020-12-310001566044-21-000010EDGAR—
2020-03-032019-12-310001564590-20-008442EDGAR—
2019-02-282018-12-310001564590-19-005451EDGAR—
2018-03-282017-12-310001628280-18-003726EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001566044-25-000010EDGAR29K words
2025-08-142025-06-300001628280-25-040366EDGAR—
2025-05-082025-03-310001628280-25-023740EDGAR—
2024-11-072024-09-300001628280-24-046244EDGAR—
2024-08-142024-06-300001628280-24-037176EDGAR—
2024-05-092024-03-310001628280-24-022183EDGAR—
2023-11-132023-09-300001628280-23-038414EDGAR—
2023-08-142023-06-300001628280-23-029334EDGAR—
2023-05-112023-03-310001628280-23-017583EDGAR—
2022-11-142022-09-300001628280-22-029836EDGAR—
2022-08-122022-06-300001628280-22-022687EDGAR—
2022-05-122022-03-310001628280-22-014092EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-110001104659-26-026439EDGAR1K words
2026-01-300001104659-26-008642EDGAR—
2025-12-170001104659-25-121828EDGAR—
2025-12-120001104659-25-120637EDGAR—
2025-11-060001566044-25-000007EDGAR—
2025-09-120001104659-25-089531EDGAR—
2025-08-140001104659-25-078135EDGAR—
2025-07-300001104659-25-071953EDGAR—
2025-05-080001628280-25-023478EDGAR—
2025-03-060001628280-25-010777EDGAR—

178 total filings indexed. 147 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001566044
TickerVYNE
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 691ac658947f3e66e6d23159dba635ccb8c46367bc9e2995cb9588925595f043
parent: c96fc91a391d8dfb1f8334f972454dce50ff1d0774e077ecdd9e357b533610eb
content hash: 0bdb0b6e2e0af402cc648c3b22d7d4cfca79582d1c7889705bb63e15e1aa9948
signed: 2026-04-13T04:48:10.171Z
sources: 21 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf